improv
microarray
fabric
scan
technolog
enabl
product
highdens
array
facilit
detect
viral
isol
even
belong
larg
divers
famili
method
develop
identifi
conserv
nucleic
acid
region
common
larger
group
lineag
serogroup
genera
famili
therebi
minim
number
probe
requir
increas
chanc
detect
novel
virus
recent
strategi
achiev
includ
use
pairwis
sequenc
comparison
identifi
conserv
sequenc
probe
well
ii
identifi
specif
region
multipl
sequenc
align
addit
group
develop
method
design
probe
within
conserv
protein
region
final
oligonucleotid
tile
array
use
viral
resequenc
appli
viru
detect
viral
transcript
profil
although
best
practic
establish
fluoresc
signal
analysi
express
profil
standard
yet
attain
pathogen
detect
array
lowdens
microarray
analyz
visual
inspect
highdens
array
requir
comput
solut
correl
fluoresc
predict
hybrid
signal
use
infer
presenc
viru
ttest
base
method
also
valid
dataset
method
includ
semisupervis
classif
use
knearest
neighbor
techniqu
empir
determin
signal
cutoff
tile
array
likelihood
metric
inform
taxonom
hierarchi
resequenc
array
abl
leverag
redund
deepcoverag
therebi
help
scientist
infer
viral
nucleotid
sequenc
whether
highli
diverg
strain
virus
correctli
annot
method
unclear
pathogen
microarray
data
noisi
viral
signatur
mask
crosshybrid
host
transcript
bias
templat
amplif
imperfectli
match
probe
result
differ
probe
sensit
addit
small
proport
probe
like
hybrid
viru
present
sampl
lead
distribut
high
varianc
nonparametr
test
transform
data
rank
order
categori
effect
rescal
varianc
simplifi
distribut
one
easili
model
data
varianc
high
distribut
heavili
skew
nonparametr
test
conserv
equival
parametr
test
nonparametr
test
valid
small
sampl
size
less
advantag
case
presenc
viru
investig
small
number
probe
nonparametr
method
mann
whitney
u
test
appli
detect
differenti
gene
express
microarray
compar
abil
three
specif
nonparametr
statist
test
predict
presenc
viral
agent
hybrid
experi
three
test
mannwhitney
u
test
central
tendenc
spearman
rank
correl
coeffici
measur
relat
two
variabl
chisquar
test
event
probabl
base
binomi
distribut
along
neg
control
nine
viral
isol
differ
famili
hybrid
isol
genom
size
rang
kilobas
type
error
result
multipl
test
control
use
method
creat
jd
storey
posit
predict
valu
fals
posit
rate
use
assess
abil
three
differ
statist
method
identifi
virus
microarray
fabric
wherein
probe
synthes
situ
agil
technolog
inc
santa
clara
ca
two
orient
plu
code
sens
minu
noncod
antisens
revers
complement
probe
coval
anchor
end
test
purpos
microarray
fabric
wherein
probe
deposit
orient
duplic
greenechip
pilot
total
probe
barcod
gene
express
omnibu
geo
platform
http
wwwncbinlmnihgovgeo
anoth
microarray
fabric
larger
number
viru
specif
probe
deposit
orient
singli
greenechip
total
probe
barcod
geo
platform
neg
control
probe
gener
randomlychosen
shuffl
viral
probe
sequenc
probe
use
proport
nucleotid
viral
probe
homolog
known
sequenc
probe
randomli
posit
array
approxim
clinic
sampl
context
yet
allow
examin
wide
rang
viral
target
hybrid
experi
conduct
known
concentr
wnv
viral
extract
spike
reaction
contain
either
nanogram
ng
human
lung
tissu
rna
data
avail
geo
seri
see
summari
data
avail
addit
file
employ
virus
vari
genom
type
length
assess
sensit
specif
three
method
statist
analyz
viral
microarray
data
data
pool
includ
three
singlestrand
posit
sens
rna
virus
west
nile
viru
wnv
strain
new
york
ca
kb
sar
coronaviru
hcovsar
strain
ca
kb
human
echoviru
strain
metcalf
atcc
ca
kb
two
segment
singlestrand
neg
sens
rna
virus
lassa
viru
lasv
strain
josiah
ca
kb
kb
influenza
viru
flua
segment
ca
kb
two
nonseg
singlestrand
neg
sens
rna
virus
zair
ebolaviru
zebov
ca
kb
vesicular
stomat
viru
vsv
indiana
strain
ca
kb
two
doublestrand
dna
virus
human
adenoviru
atcc
ca
kb
human
herpesviru
viral
cultur
ca
kb
see
tabl
data
avail
geo
seri
addit
file
random
amplif
dendrim
label
complet
array
visual
agil
slide
scanner
spss
version
http
wwwspsscom
use
statist
analysi
data
plot
databas
probeviru
target
homolog
creat
use
analysi
algorithm
embl
viral
nucleotid
sequenc
databas
filter
short
sequenc
combin
ncbi
viral
referencesequ
databas
nonredund
databas
sequenc
gener
cdhit
use
similar
cutoff
defin
sequenc
ident
probe
sequenc
compar
nonredund
set
viral
sequenc
number
posit
mismatch
store
probeviru
target
pair
chang
gibb
free
energi
hybrid
temperatur
calcul
measur
probetarget
bind
strength
tabl
valu
avail
geo
seri
proberevers
complement
hybrid
also
calcul
probe
higher
gc
content
greater
lowess
fit
proberevers
complement
fluoresc
signal
comput
hybrid
use
correct
sequenc
composit
close
relat
virus
may
indistinguish
hybrid
profil
eg
intens
signal
probe
valu
identifi
set
viral
sequenc
record
like
distinguish
array
use
valu
comput
silico
hybrid
profil
use
comput
distanc
cutoff
kj
use
determin
whether
probe
like
hybrid
silico
hybrid
profil
differ
less
probe
consolid
assess
applic
analyt
method
anoth
pathogen
microarray
platform
use
epredict
train
set
http
wwwncbinlmnihgovgeo
access
inclus
dataset
compris
virochip
microarray
hybrid
viral
sampl
previous
character
direct
immunofluoresc
virus
repres
human
papillomaviru
sampl
deriv
hela
cell
influenza
viru
sampl
deriv
nasal
lavag
hepat
b
sampl
deriv
serum
respiratori
syncyti
viru
sampl
deriv
nasal
lavag
human
rhinoviru
sampl
deriv
viral
cultur
cell
line
one
clinic
isol
influenza
viru
also
contain
respiratori
syncyti
viru
array
compris
probe
probe
exclud
epredict
analysi
also
exclud
studi
ttest
anova
test
common
form
statist
test
microarray
analysi
literatur
success
appli
pathogen
array
mannwhitney
u
test
also
call
wilcoxon
ranksum
test
nonparametr
analogu
student
ttest
use
rank
data
assess
whether
two
group
sampl
drawn
distribut
experiment
applic
signal
viral
probe
target
singl
strain
compar
equal
number
neg
control
probe
viru
target
less
probe
neg
control
probe
supplement
achiev
n
null
hypothesi
viru
specif
probe
neg
control
probe
central
tendenc
eg
drawn
popul
instanc
signific
u
statist
comput
commonlyus
normal
approxim
larg
sampl
correl
strength
linear
relationship
two
variabl
common
method
assess
correl
two
continu
variabl
pearson
productmo
correl
coeffici
normal
data
distribut
requir
test
although
equal
varianc
homoscedast
assum
varianc
assumpt
shown
confound
microarray
analysi
thu
decid
use
conserv
correl
measur
make
use
rank
data
name
spearman
rank
correl
coeffici
applic
chang
gibb
free
energi
valu
predict
probeviru
target
hybrid
use
independ
variabl
depend
variabl
observ
probe
signal
see
graphic
exampl
use
predict
fluoresc
model
surfac
hybrid
kinet
equal
number
neg
control
probe
pool
viral
probe
ensur
wide
rang
signal
would
examin
necessari
ensur
correl
could
comput
uniformli
high
signal
would
regard
uncorrel
valu
neg
control
probe
independ
variabl
predict
human
ribosom
rna
duplex
null
hypothesi
fluoresc
signal
would
predict
eg
signal
might
rather
randomli
distribut
respect
one
side
pvalu
correl
comput
use
standard
student
tdistribut
approxim
binomi
test
subset
chisquar
method
test
probabl
observ
seri
event
accord
expect
probabl
rate
exampl
kind
test
would
assess
fair
game
dice
applic
bin
probe
signal
percentil
categor
posit
neg
base
whether
comput
valu
locat
certain
threshold
probe
singl
viru
test
distribut
way
expect
probabl
equal
probabl
rate
neg
control
probe
null
hypothesi
threshold
differ
proport
viru
specif
probe
neg
control
probe
threshold
choic
binomi
test
clearli
strong
influenc
result
exploratori
test
variou
percentil
threshold
show
percentil
gener
best
perform
need
binomi
test
conduct
use
percentil
categor
probe
posit
neg
conclud
threshold
valu
test
whatev
might
consid
paramet
optim
issu
often
aris
test
seri
null
hypothes
increas
probabl
occurr
type
error
eg
reject
true
conserv
familywis
correct
method
bonferroni
appli
microarray
data
altern
method
first
describ
benjamini
hochberg
revis
storey
involv
correct
proport
fals
reject
hypothes
use
storey
method
defin
paramet
within
studi
proport
virus
identifi
array
hybrid
prove
fals
lead
ie
qvalu
multipl
hypothesi
test
scenario
requir
q
valu
signific
would
indic
virus
identifi
present
sampl
may
fact
truli
absent
contrast
requir
p
valu
signific
indic
truli
absent
virus
may
identifi
present
qvalu
calcul
test
pvalu
use
qvalu
modul
r
project
contribut
storey
tabl
correct
predict
hybrid
viru
creat
use
ncbi
taxonomi
databas
avail
addit
file
predict
consid
true
posit
either
specif
viru
introduc
experi
viru
genu
therebi
predict
qvalu
threshold
use
top
predict
method
evalu
speci
predict
could
also
assess
would
less
indic
algorithm
perform
concept
constitut
viral
speci
compar
variou
taxonom
famili
eg
serolog
molecular
phylogeni
highli
similar
strain
may
imposs
distinguish
examin
microarray
signatur
yet
still
defin
differ
speci
contrast
virus
differ
genera
easili
distinguish
fals
posit
rate
fpr
posit
predict
valu
ppv
use
assess
perform
variou
test
model
ppv
commonli
use
standard
diagnost
test
probabl
posit
test
result
reflect
presenc
viru
sampl
ppv
ratio
number
true
posit
sum
number
true
posit
fals
posit
fals
neg
use
ppv
method
particular
applic
method
ratio
number
statist
signific
q
correct
predict
sum
statist
signific
predict
gener
predict
signific
threshold
ignor
ppv
use
measur
algorithm
perform
sensit
heterogen
misclassif
viral
taxonomi
necessari
predict
member
genu
present
order
achiev
favor
score
assess
effect
variabl
deriv
concentr
viral
nucleic
acid
host
nucleic
acid
clinic
sampl
character
effect
vari
input
human
rna
fluoresc
distribut
logtransform
probe
signal
analysi
gile
kipl
affymetrix
array
base
nt
probe
indic
fluoresc
distribut
logtransform
probe
signal
inde
close
normal
gaussian
experi
nt
probe
array
show
strong
deviat
normal
distribut
increas
rna
input
complex
effect
signal
distribut
degre
skew
increas
upper
tail
lengthen
see
figur
test
normal
distribut
found
strong
deviat
three
experi
use
kolmogorovsmirnov
test
p
sampl
distribut
fluoresc
signal
deriv
virusinfect
tissuecultur
cell
hybrid
avail
addit
file
figur
observ
signal
distribut
includ
gaussian
highli
kurtot
bimod
host
rna
concentr
partial
explain
differ
explan
includ
larg
proport
homolog
probe
array
increas
upper
tail
differ
amplif
label
effici
sampl
sampl
differ
hybrid
affin
due
guaninecytosin
proport
viral
transcript
complex
method
transform
describ
elsewher
focus
improv
sensit
transcript
profil
measur
surmis
unlik
improv
sensit
applic
parametr
analysi
microarray
data
particularli
sensit
transform
violat
normal
lead
loss
power
may
result
invalid
p
valu
replic
hybrid
experi
improv
specif
howev
expens
incur
process
multipl
array
low
quantiti
nucleic
acid
one
clinic
sampl
may
preclud
use
approach
altern
strategi
might
adopt
includ
applic
either
replic
probe
andor
revers
complementari
probe
array
studi
use
agil
nt
insitu
synthes
array
found
replic
probe
highli
concord
use
improv
normal
identifi
outlier
signal
revers
complement
use
spot
oligonucleotid
array
pathogen
although
quantit
assess
advantag
report
point
studi
mention
situ
synthes
oligonucleotid
immobil
end
probetarget
helix
stabil
near
surfac
like
reduc
due
steric
hindranc
thu
probe
mismatch
target
strongli
affect
specif
mismatch
posit
eg
mismatch
near
end
reduc
hybrid
signal
near
end
identifi
print
strategi
would
reduc
fals
posit
signal
conduct
pilot
studi
use
infect
cell
extract
wnv
contain
copi
viral
templat
rna
input
revers
transcriptas
reaction
amplif
product
hybrid
array
contain
replic
revers
complement
probe
human
lung
rna
use
control
experi
replic
probe
pair
better
correl
revers
complement
pair
wnv
cognat
probe
nonflaviviru
probe
wnv
present
revers
complement
probe
higher
correl
wnv
present
differenti
respons
stronger
probe
highest
degre
signal
ie
top
percentil
see
tabl
addit
file
figur
seven
neg
control
hybrid
nine
viral
isol
hybrid
use
comput
fals
posit
rate
fpr
see
tabl
top
predict
statist
test
evalu
qvalu
threshold
appli
correspond
condit
predict
may
prove
fals
binomi
test
perform
well
achiev
fals
posit
rate
wherea
mannwhitney
u
spearman
correl
test
high
averag
fpr
respect
see
tabl
notic
strong
relationship
exist
gc
content
fluoresc
signal
platform
see
addit
file
figur
worth
note
high
gc
content
h
previous
implic
offtarget
hybrid
appli
probelevel
correct
found
substanti
decreas
fpr
occur
case
mannwhitney
u
spearman
correl
method
result
see
tabl
data
avail
addit
file
addit
file
even
gc
correct
strong
predict
chicken
endogen
retroviru
identifi
influenza
viru
hybrid
three
method
viru
cultur
egg
like
express
viral
transcript
indic
microarray
inde
identifi
coinfect
statist
method
compar
gccorrect
signal
use
ppv
posit
predict
valu
probabl
diagnost
test
correctli
report
caus
agent
ill
clinic
applic
identif
viral
genu
suffici
direct
molecular
identif
method
eg
consensu
pcr
well
prescrib
initi
clinic
measur
thu
measur
success
statist
method
whether
correctli
predict
presenc
hybrid
viral
isol
viru
within
genu
precis
number
time
statist
signific
predict
prove
correct
also
tabul
see
tabl
enumer
measur
statist
analysi
carri
code
sens
probe
antisens
probe
probe
type
pool
togeth
independ
measur
quantiti
viral
nucleic
acid
strategi
averag
probe
valu
result
perform
similar
instanc
code
sens
probe
alon
use
binomi
test
obtain
highest
ppv
sens
probe
antisens
probe
taken
account
mannwhitney
u
test
also
perform
favor
contrast
spearman
correl
coeffici
test
substanti
lower
ppv
relax
multipletest
correct
requir
result
improv
spearman
ppv
antisens
probe
relax
correct
requir
undesir
due
potenti
rise
fals
posit
might
result
see
addit
file
tabl
two
case
use
sens
antisens
probe
reduc
overal
ppv
howev
input
viru
nonetheless
correctli
predict
anoth
case
lasv
binomi
test
pool
two
probe
method
result
detect
viru
would
otherwis
miss
public
avail
dataset
urisman
et
al
virochip
epredict
train
set
download
analyz
use
mannwhitney
u
binomi
test
virochip
dataset
compris
hybrid
sampl
deriv
tissu
cultur
nasal
lavag
serum
sampl
contain
papillomaviru
influenza
viru
hepat
b
viru
respiratori
syncyti
viru
human
rhinoviru
virochip
platform
differ
follow
way
oligonucleotid
probe
length
nt
vs
number
probe
vs
fabric
method
robot
spot
vs
situ
synthesi
incorpor
fluoresc
aminoallyl
dutp
vs
secondari
hybrid
presenc
gcmatch
neg
control
probe
howev
virochip
platform
includ
use
revers
complement
probe
employ
randompcr
base
nucleic
acid
amplif
strategi
similar
two
method
epredict
detectiv
report
high
degre
predict
accuraci
use
examin
dataset
similarli
report
achiev
high
degre
accuraci
use
two
nonparametr
test
method
binomi
test
mannwhitney
u
togeth
paramet
use
insitu
synthes
probe
platform
report
perform
instanc
reli
simpl
metric
rank
first
correct
predict
see
tabl
first
predict
mannwhitney
u
test
correct
case
correct
predict
present
among
first
ten
predict
case
averag
correct
predict
rank
mannwhitney
u
test
largest
number
incorrect
predict
human
herpesviru
human
herpesviru
human
herpesviru
regardless
sampl
sourc
first
predict
binomi
test
correct
case
correct
predict
present
among
first
ten
predict
case
averag
correct
predict
rank
binomi
test
mannwhitney
u
result
major
incorrect
predict
watson
et
al
report
similar
falseposit
result
use
ttest
method
seroprevel
human
readili
detect
blood
saliva
cervic
tissu
degre
preval
suggest
predict
repres
true
coinfect
howev
valid
would
requir
molecular
test
binomi
mannwhitney
u
method
gener
statist
signific
predict
influenza
viru
rsv
coinfect
sampl
binomin
test
outperform
mannwhitney
test
virochip
data
larg
mannwhitney
rank
lower
binomi
test
perform
without
optim
compar
epredict
correct
first
predict
correct
first
ten
detectiv
correct
first
predict
correct
first
ten
howev
binomi
test
requir
probelevel
weight
assumpt
normal
although
express
profil
viral
microarray
may
employ
similar
method
print
probe
prepar
hybrid
nucleic
acid
differ
markedli
analyt
strategi
fundament
assumpt
express
profil
major
variou
gene
transcript
mrna
present
sampl
albeit
differ
concentr
differenti
express
identifi
comput
ratio
probe
signal
gene
two
condit
eg
tumor
vs
normal
tissu
viral
microarray
experi
absenc
signal
probe
plausibl
result
may
reflect
follow
agent
present
agent
present
probe
either
truli
new
suffici
differ
confound
hybrid
known
agent
present
probe
appropri
level
insuffici
enabl
detect
result
present
indic
quantiti
host
nucleic
acid
use
hybrid
substant
effect
probe
fluoresc
signal
distribut
manifest
deviat
normal
specul
deviat
repres
mass
effect
concentr
high
enough
drive
proport
partial
hybrid
strand
probe
sequenc
composit
identifi
major
confound
result
high
fpr
probe
signal
correct
gc
content
improv
predict
test
effect
variou
probe
control
strategi
fpr
hybrid
requir
sens
antisens
probe
help
reduc
fpr
use
hybrid
replic
probe
addit
import
neg
control
inclus
shuffl
viral
probe
enabl
examin
effect
arraywid
gc
content
key
strength
studi
effect
control
familywis
error
rate
achiev
via
use
storey
fdr
techniqu
method
success
lower
fpr
mild
violat
independ
assumpt
probe
target
multipl
virus
q
valu
remain
use
p
valu
correl
within
block
condit
expect
true
within
probeset
method
explicitli
address
depend
recent
investig
incorpor
futur
version
method
nonparametr
statist
method
conserv
equival
parametr
one
consequ
less
like
requir
one
reject
null
hypothesi
fals
case
type
ii
error
fals
neg
variabl
microarray
signal
distribut
studi
suggest
parametr
predict
may
inaccur
reason
test
number
nonparametr
approach
three
method
assess
binomi
test
success
achiev
ppv
develop
studi
might
includ
empir
determin
optim
threshold
use
spikein
control
ad
categori
reflect
differ
level
confid
eg
posit
margin
neg
mannwhitney
u
test
also
success
predict
presenc
nearli
agent
result
conform
similar
studi
use
ttest
yet
mannwhitney
u
assess
sensit
sequenc
composit
ppv
uncorrect
signal
data
spearman
correl
perform
poorli
correctli
predict
three
diseas
agent
pearson
correl
method
epredict
success
appli
pathogen
array
accord
urisman
et
al
epredict
method
perform
silico
hybrid
fulli
sequenc
viral
genom
viral
array
clinic
sampl
hybrid
predict
fluoresc
viru
compar
observ
signal
strength
correl
use
identifi
viru
respons
signal
pattern
studi
urisman
spearman
correl
perform
poorli
reexplor
result
relax
requir
multipl
test
correct
found
improv
degre
predict
accuraci
spearman
assess
still
perform
well
test
see
addit
file
tabl
accordingli
conclud
spearman
correl
implement
discrimin
nonparametr
test
report
success
applic
two
nonparametr
test
requir
assumpt
high
degre
predict
accuraci
extrem
low
fals
posit
rate
direct
assess
binomi
mannwhitney
u
test
relat
pathogen
microarray
platform
binomi
test
perform
compar
report
method
eg
epredict
detectiv
contrast
method
binomi
test
achiev
high
degre
predict
accuraci
rank
data
without
probespecif
weight
paramet
iter
analysi
assumpt
normal
pq
jh
carri
viru
cultur
quantit
microarray
hybrid
experi
gp
tb
help
design
microarray
devis
experi
mh
provid
statist
advic
oj
sc
program
analyt
techniqu
wrote
manuscript
wil
oj
design
analyz
variou
experi
author
read
approv
final
manuscript
